ID: ALA91633

Max Phase: Preclinical

Molecular Formula: C6H10N2O6S

Molecular Weight: 238.22

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  COC(=O)C(=O)NCC(=O)NS(C)(=O)=O

Standard InChI:  InChI=1S/C6H10N2O6S/c1-14-6(11)5(10)7-3-4(9)8-15(2,12)13/h3H2,1-2H3,(H,7,10)(H,8,9)

Standard InChI Key:  XACUKMLITUICBQ-UHFFFAOYSA-N

Associated Targets(non-human)

P4ha1 Prolyl 4-hydroxylase alpha-1 subunit (36 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 238.22Molecular Weight (Monoisotopic): 238.0260AlogP: -2.65#Rotatable Bonds: 3
Polar Surface Area: 118.64Molecular Species: ACIDHBA: 6HBD: 2
#RO5 Violations: 0HBA (Lipinski): 8HBD (Lipinski): 2#RO5 Violations (Lipinski): 0
CX Acidic pKa: 3.91CX Basic pKa: CX LogP: -2.31CX LogD: -3.26
Aromatic Rings: 0Heavy Atoms: 15QED Weighted: 0.41Np Likeness Score: -0.80

References

1. Cunliffe CJ, Franklin TJ, Hales NJ, Hill GB..  (1992)  Novel inhibitors of prolyl 4-hydroxylase. 3. Inhibition by the substrate analogue N-oxaloglycine and its derivatives.,  35  (14): [PMID:1321909] [10.1021/jm00092a016]

Source